SCHEMBL712468

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL712448	0.89	—	—
	SCHEMBL10265873	0.84	CHRNB2 (0.35)	ALDH1A1GLA
	SCHEMBL713489	0.78	APP (0.38)	ALDH1A1GLA
	SCHEMBL13358810	0.77	ALDH1A1 (0.30)	ALDH1A1GLA
	SCHEMBL714082	0.77	AGXT (0.37)	—
	SCHEMBL713299	0.75	KCNJ5 (0.38)	SMN1; SMN2ALDH1A1GLA
	SCHEMBL714260	0.74	IRAK4 (0.33)	ALDH1A1GLA
	SCHEMBL712494	0.73	IRAK4 (0.31)	—
	SCHEMBL711056	0.72	IRAK4 (0.32)	—
	SCHEMBL10265511	0.72	CHRNB2 (0.35)	ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.